Gravitas Medical, Inc.
PrivateLast Round
Series A
Extension
Sep 28, 2022
Total Funding Raised
$9.4M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Gravitas Medical, Inc. operates in Healthcare & Life Sciences and is based in Berkeley, California. Its latest recorded funding round was a Series A Extension round in September 2022.
Gravitas Medical, Inc. is a medical device company that develops smart enteral feeding technologies, including sensor-enabled feeding tubes and monitoring systems, to provide real-time guidance and data-driven insights for patient nutrition.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gravitas Medical, Inc. Comparables
Compare Gravitas Medical, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NGpod Global | 85% | |
| ART Medical Ltd. | 83% | |
| ENvue Medical, Inc. | 82% |
For institutional investors. Book with your work email.
Gravitas Medical, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Sep 28, 2022 | ||||
| Series A | May 10, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Gravitas Medical, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Serial Stage Venture Partners | Series A Extension |
| MedTech Innovator | Series A Extension |
| TheraNova | Series A |
| Ehrenberg Chesler Capital Partners | Series A Extension |
| QB3 | Series A Extension |
| Green Park & Golf Ventures | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 2, 2026
Open roles increased from 0 to 3, representing 25% of headcount.
- Jul 24, 2026
Grew 27% QoQ, from 11 to 14 employees.
For institutional investors. Book with your work email.
Gravitas Medical, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Gravitas Medical, Inc.'s valuation, stock price, and market status.
Is Gravitas Medical, Inc. a public or private company?
Gravitas Medical, Inc. is a private company.
What is the current stock price of Gravitas Medical, Inc.?
Gravitas Medical, Inc. is a private company, so its shares have no public market price. Caplight tracks Gravitas Medical, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Gravitas Medical, Inc. worth (valuation)?
Valuation information for Gravitas Medical, Inc. is not publicly available.
Can I buy Gravitas Medical, Inc. stock?
Gravitas Medical, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Gravitas Medical, Inc.'s last funding round?
Gravitas Medical, Inc.'s most recent funding round was Series A Extension on September 28, 2022.
Who are the main investors in Gravitas Medical, Inc.?
Key investors in Gravitas Medical, Inc. include Serial Stage Venture Partners, MedTech Innovator, TheraNova, Ehrenberg Chesler Capital Partners, QB3.
Will Gravitas Medical, Inc. IPO soon?
No public IPO plans have been announced for Gravitas Medical, Inc..
How can I track Gravitas Medical, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Gravitas Medical, Inc.'s shares on secondary markets.